VEGF in the treatment and prognosis of lung cancer
10.3760/cma.j.issn.1673-422X.2012.04.014
- VernacularTitle:血管内皮生长因子与肺癌的治疗和预后
- Author:
Qiu ZHAO
;
Renhua GUO
- Publication Type:Journal Article
- Keywords:
Vascular endothelial growth factors;
Lung neoplasms;
Prognosis
- From:
Journal of International Oncology
2012;39(4):286-288
- CountryChina
- Language:Chinese
-
Abstract:
Angiogenesis plays a critical role in growth and metastasis of lung cancer.The strongest tumor angiogenesis factor known is the vascular endothelial growth factor (VEGF).Therefore,anti-VEGF therapy which can restrain tumor angiogenesis is an important form of the targeted therapy of lung cancer.The expression of VEGF is also significant to the prognosis of lung cancer.